Cognetivity Neurosciences Ltd. (CGNSF)
USD 0.0
(-94.74%)
USD 0.0
(-94.74%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.09 CAD | 58.06% |
| 2022 | -0.18 CAD | -447.11% |
| 2021 | -0.03 CAD | 43.28% |
| 2020 | -0.06 CAD | 42.0% |
| 2019 | -0.10 CAD | -177.01% |
| 2018 | -0.04 CAD | -225.23% |
| 2017 | -0.01 CAD | -455.0% |
| 2016 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.02 CAD | 9.76% |
| 2024 Q3 | -0.02 CAD | -3.6% |
| 2024 Q1 | -0.02 CAD | 18.54% |
| 2023 Q4 | -0.03 CAD | -33.63% |
| 2023 Q3 | -0.02 CAD | -13.0% |
| 2023 Q2 | -0.02 CAD | 1.48% |
| 2023 Q1 | -0.02 CAD | 68.96% |
| 2023 FY | - CAD | 58.06% |
| 2022 Q2 | -0.01 CAD | -16.13% |
| 2022 FY | - CAD | -447.11% |
| 2022 Q4 | -0.07 CAD | 22.79% |
| 2022 Q1 | -0.01 CAD | 20.0% |
| 2022 Q3 | -0.08 CAD | -488.19% |
| 2021 FY | - CAD | 43.28% |
| 2021 Q4 | -0.02 CAD | -868.75% |
| 2021 Q3 | -0.00 CAD | 85.59% |
| 2021 Q2 | -0.01 CAD | -226.47% |
| 2021 Q1 | -0.00 CAD | 52.78% |
| 2020 Q4 | -0.01 CAD | 56.1% |
| 2020 Q1 | -0.02 CAD | 20.55% |
| 2020 Q2 | -0.02 CAD | 1.15% |
| 2020 FY | - CAD | 42.0% |
| 2020 Q3 | -0.02 CAD | 4.65% |
| 2019 Q4 | -0.02 CAD | 6.01% |
| 2019 FY | - CAD | -177.01% |
| 2019 Q3 | -0.02 CAD | -46.54% |
| 2019 Q2 | -0.02 CAD | 65.36% |
| 2019 Q1 | -0.05 CAD | -42.99% |
| 2018 Q2 | -0.00 CAD | -100.0% |
| 2018 FY | - CAD | -225.23% |
| 2018 Q3 | -0.01 CAD | -97.62% |
| 2018 Q4 | -0.03 CAD | -286.75% |
| 2018 Q1 | -0.00 CAD | 55.32% |
| 2017 Q3 | -0.00 CAD | 0.0% |
| 2017 Q4 | -0.00 CAD | -20.51% |
| 2017 FY | - CAD | -455.0% |
| 2016 FY | - CAD | 0.0% |